Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2025-12-27 @ 7:18 AM
Study NCT ID:
NCT01914757
Status:
COMPLETED
Last Update Posted:
2017-01-25
First Post:
2013-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-31
First Submit QC Date:
None
Study First Post Date:
2013-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-08
Results First Submit QC Date:
None
Results First Post Date:
2017-01-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-30
Last Update Post Date:
2017-01-25
Last Update Post Date Type:
ESTIMATED